LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 70.05 | 770.25 | 7505 | 10413 | 0.7207 | 0.8330 | MN20160304_L02 | M16 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 72.27 | 770.25 | 6406 | 10730 | 0.5970 | 0.7461 | MN20160304_L02 | F11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 72.27 | 770.25 | 7752 | 10730 | 0.7224 | 0.8360 | MN20160304_L02 | M16 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 74.50 | 770.25 | 6569 | 10991 | 0.5976 | 0.7488 | MN20160304_L02 | F11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 74.50 | 770.25 | 8083 | 10991 | 0.7354 | 0.8460 | MN20160304_L02 | M16 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 76.75 | 770.25 | 6828 | 11262 | 0.6062 | 0.7574 | MN20160304_L02 | F11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 76.75 | 770.25 | 8417 | 11262 | 0.7473 | 0.8550 | MN20160304_L02 | M16 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 78.98 | 770.25 | 7100 | 11518 | 0.6164 | 0.7668 | MN20160304_L02 | F11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 78.98 | 770.25 | 8727 | 11518 | 0.7577 | 0.8627 | MN20160304_L02 | M16 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 81.20 | 770.25 | 7339 | 11766 | 0.6237 | 0.7738 | MN20160304_L02 | F11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 81.20 | 770.25 | 9011 | 11766 | 0.7658 | 0.8688 | MN20160304_L02 | M16 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 83.42 | 770.25 | 7673 | 12031 | 0.6377 | 0.7855 | MN20160304_L02 | F11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 83.42 | 770.25 | 9313 | 12031 | 0.7740 | 0.8749 | MN20160304_L02 | M16 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 85.64 | 770.25 | 8041 | 12287 | 0.6544 | 0.7986 | MN20160304_L02 | F11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 85.64 | 770.25 | 9702 | 12287 | 0.7896 | 0.8852 | MN20160304_L02 | M16 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 87.86 | 770.25 | 8397 | 12543 | 0.6694 | 0.8102 | MN20160304_L02 | F11 |
MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 87.86 | 770.25 | 10071 | 12543 | 0.8029 | 0.8939 | MN20160304_L02 | M16 |
MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 3.21 | 770.25 | 924 | 904 | 1.0214 | 1.1913 | MN20160304_L02 | C17 |
MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 3.21 | 770.25 | 931 | 904 | 1.0292 | 1.2638 | MN20160304_L02 | K10 |
MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 5.44 | 770.25 | 1018 | 1012 | 1.0052 | 1.0264 | MN20160304_L02 | C17 |
MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 5.44 | 770.25 | 1074 | 1012 | 1.0605 | 1.3207 | MN20160304_L02 | K10 |
MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 7.66 | 770.25 | 1124 | 1090 | 1.0312 | 1.1265 | MN20160304_L02 | C17 |
MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 7.66 | 770.25 | 1165 | 1090 | 1.0688 | 1.2841 | MN20160304_L02 | K10 |
MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 10.06 | 770.25 | 1184 | 1218 | 0.9717 | 0.9151 | MN20160304_L02 | C17 |
MCF 10A-H2B-mCherry | Palbociclib | 0.17783 | 10.06 | 770.25 | 1263 | 1218 | 1.0365 | 1.1114 | MN20160304_L02 | K10 |